Web Content Management
PRODUCTS
-
The Challenge: Building Scalable Viral Vector Programs
Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.
-
This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.
All In-line Gain, No Modeling Pain
MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.
-
Increase efficiency with fast and simple two-way data sharing between the Sartorius Ambr® 250 and Waters BioAccord LC-MS System.
-
1,735 eCOA & ePRO Studies Completed
eCOA and ePRO with Enrollment, eConsent, Payments and EDC integrated. Our services cover build, licensing and 24/7 support.
95%+ Patient Compliance Rate
4-8 Weeks to Deploy
190+ Validated Instruments
-
ISOPRIME Isolators
ISOPRIME is the ideal solution for customers with modular rigid-wall isolator requirements that combine high quality, versatility, and continuous operations at a competitive price point.
WHITE PAPERS AND CASE STUDIES
-
Addressing A Global Health Priority In Australia And New Zealand
For sponsors navigating a competitive therapeutic landscape, this case underscores how regional execution excellence can accelerate global impact.
-
Zero Disruptions: Migrating 14 Mid-Study Clinical Trials In 16 Months
Uncover how Imperial College London was able to effectively transfer 14 ongoing studies, encompassing over 1,700 patients and 150,000+ forms, onto a new EDC platform within 16 months.
-
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection
Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
-
Scaling Hope: Growth Of The Allogeneic Cell Therapy Sector
By utilizing cells from donors which are then modified and stored in large batches, allogeneic therapies enable accelerated timelines and larger-scale preparation.
-
PFAS Removal System Proven Effective In Removing Both Long And Short Chain PFAS
A new system removed all nine PFAS compounds from a municipality's water to non-detect levels in a single pass. Unlike traditional methods, it addresses both long- and short-chain PFAS while generating minimal waste.
-
Laser Power Monitoring Reduces Loss For This EV Battery Manufacturer
Discover how a two-part solution helped enhance and ensure precision and minimize defects for a battery manufacturer facing a critical challenge in their laser welding process.
-
The Burden Of MES Vendor Cloud Migration In Drug Manufacturing
Uncover the challenges and limitations of on-premise MES vendor cloud migration, and explore the modern, cloud-based solutions that can circumvent them.
-
Real-World Data: Digitalizing A Patient's Prescription Journey In Japan
Explore how Japan’s healthcare system provides the most comprehensive RWD by giving access to the complete patient journey through both in- and out-of-hospital pharmacy records as well as personal health records.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
Agentic AI And How It's Impacting Clinical Trial Research
Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.
-
Repairing A Suspended Pipe Within 30 Minutes With HYMAX Permanent Repair Sleeve
In the picturesque village of Arzacq-Arraziguet in southwestern France, a critical water pipeline repair showcased the efficiency of modern tools and techniques.
-
Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments
A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.
NEWS
-
Philips Launches Next-Generation Web-Based Diagnostic Viewer For Fast, Secure Imaging Data Access Anywhere11/24/2025
Royal Philips a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, web diagnostic viewer [1] that transforms how radiologists access and interpret medical images.
-
SoftServe Unveils New Gen AI Solution 'Drug Discovery,' Built With NVIDIA Blueprints At AWS Re:Invent 202412/3/2024
SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug Discovery, alongside its partner NVIDIA at AWS re:Invent 2024.
-
Crucial Data Solutions And nmible Join Forces To Provide A Solution For Seamless Participant Reimbursement In Clinical Trials2/12/2024
Crucial Data Solutions (CDS), the only SaaS platform to empower customer-driven global clinical trials for web and mobile environments, and nmible, a provider of cost effective clinical trial payment solutions, announced today they have formed a strategic partnership.
-
Microbes In Brooklyn Superfund Site Teach Lessons On Fighting Industrial Pollution4/15/2025
NYU Tandon-led research team discovers unprecedented genetic adaptations in Gowanus Canal organisms, revealing a potential new approach for cleaning contaminated waters and recovering valuable resources.
-
Computational Approach Yields Novel Cancer Targets9/5/2024
Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors.